CHMP positive opinion recommending approval of Benlysta for adult patients with active lupus nephritis
The Pharma Data
MARCH 26, 2021
It causes inflammation in the kidneys and can lead to end-stage kidney disease which may require dialysis or a transplant. 2] LN can lead to end-stage kidney disease, which requires kidney dialysis or a transplant. Approximately 20% of patients with LN progress to end-stage kidney disease within 10 years of diagnosis. [5].
Let's personalize your content